SMAD3 and polycystic ovary syndrome: TGFB1 partially inhibits adipogenesis through SMAD3 (Tsurutani et al., 2011), and downregulation of the TGFB1 signaling pathway may promote adipogenesis by altering the expression of adipogenic genes to change the PCOS phenotype (Li and Wu, 2020).